Marty Makary, 27th Commissioner of the U.S. FDA, shared on X:
“My mother was among the 50 million+ women who were denied the potential benefits of hormone replacement therapy. She later suffered multiple bone fractures – so I was struck when a NEJM randomized controlled trial found that HRT started within 10 years of the onset of menopause can reduce the risk of bone fractures by up to 50%.”